4//SEC Filing
Markels Michael 4
Accession 0001181431-12-017851
CIK 0001385830other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 9:34 PM ET
Size
8.0 KB
Accession
0001181431-12-017851
Insider Transaction Report
Form 4
NeurogesX IncNGSX
Markels Michael
VP, Commercial Ops and Bus Dev
Transactions
- Award
Stock Option (right to buy)
2012-03-13+50,000→ 50,000 totalExercise: $0.48From: 2013-03-13Exp: 2022-03-13→ Common Stock (50,000 underlying) - Award
Stock Option (right to buy)
2012-03-13+50,000→ 50,000 totalExercise: $0.48From: 2014-03-13Exp: 2022-03-13→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The option grant shares are granted under the 2007 Stock Plan and shall vest as follows:one-hundred percent (100%) of the total number of shares subject to the option grant shall become exercisable on March 13, 2013, subject to the grantee's continued service relationship with the Company.
- [F2]The option grant shares are granted under the 2007 Stock Plan and shall vest as follows: one-hundred percent (100%) of the total number of shares subject to the option grant shall become exercisable on March 13, 2014 or upon the attainment of the Company's milestone; such milestone must be attained by December 31, 2012 or the shares shall not become exercisable until March 13, 2014, subject to the grantee's continued service relationship with the Company.
Documents
Issuer
NeurogesX Inc
CIK 0001385830
Entity typeother
Related Parties
1- filerCIK 0001394530
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 9:34 PM ET
- Size
- 8.0 KB